Introduction and overview of therapeutic apheresis - Okafor - 2010 - Journal of Clinical Apheresis - Wiley Online Library
Therapeutic plasma exchange in pregnancy: A literature review - ScienceDirect
Therapeutic plasma exchange for children with kidney disorders: Definitions, prescription, indications, and complications Alhasan KA - Saudi J Kidney Dis Transpl
Table 2 from Practical considerations for planning a therapeutic apheresis procedure. | Semantic Scholar
Frontiers | On Therapeutic Plasma Exchange Against Severe COVID-19-Associated Pneumonia: An Observational Clinical Study
Use of plasma exchange as therapeutic tool in clinical practice
US Therapeutic Plasma Exchange Market - Growth Drivers & Opportunities | MarketsandMarkets
PDF) How we approach an apheresis request for a Category III, Category IV, or noncategorized indication | Jeffrey L Winters - Academia.edu
Table 3 from Principles of separation: indications and therapeutic targets for plasma exchange. | Semantic Scholar
Principles of Plasma Exchange, Applications, & Practical Issues
Table 2 from Practical considerations for planning a therapeutic apheresis procedure. | Semantic Scholar
Modified therapeutic plasma-exchange
Table 2 from Therapeutic apheresis for patients with cancer. | Semantic Scholar
Nephrology Journal Club on Twitter: "According to the American Society of Apheresis Guideline, AAV is a category II indication for PLEX (BUT not every AAV requires PLEX) *RPGN (Cr ≥ 5.7 mg/dl)
Indications for therapeutic apheresis in hematological disorders - ScienceDirect
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of
Table 2 from Therapeutic apheresis for patients with cancer. | Semantic Scholar
Pharmaceutics | Free Full-Text | Is Antimicrobial Treatment Effective During Therapeutic Plasma Exchange? Investigating the Role of Possible Interactions
Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia | NEJM
Frontiers | Safety of Therapeutic Apheresis in Children and Adolescents
Daniela Hermelin, MD di Twitter: "According the newest ASFA 2019 guidelines, symptomatic #hyperviscosity in hypergammagobulinemia is a Category I indication, which means that it is a disease for which apheresis is considered
ASFA category I renal indications for therapeutic plasma exchange | Download Table
The diagnosis or syndromes indicating the need for plasma exchange | Download Table
